The Cabinet approves the plan to conclude agreements with the producers of COVID-19 vaccines within the scope of the COVAX facility.
The COVAX facility is a worldwide project that brings together governments and manufacturers to ensure an equitable distribution of COVID-19 vaccines between nations, thus providing safe and effective vaccines.
The production and development of COVID-19 vaccines is being accelerated through this facility, ensuring the eventual scope of the COVID-19 vaccine to every country in the world.
Cabinet Decision
Sri Lanka has already joined with the COVAX facility; and the Global Alliance for Vaccines and Immunization (GAVI), which also includes the World Health Organization, has accredited that Sri Lanka is eligible to receive the COVID-19 vaccines through this facility.
Countries are informed to submit vaccine request applications under two phases to receive the vaccine facility and the first part and part A which includes the information regarding the target group, store capacity, and technical information was submitted by Sri Lanka before the deadline on 07th December 2020.
The second part thereof regarding the receiving of vaccines and signing the compensatory agreement has to submit before 08th January 2021.
As per the proposal tabled by the Minister of Health Pavithra Wanniarachchi the Cabinet granted its approval to submit part B of the vaccine application according to the guidelines provided by the Attorney General and to sign an agreement with the manufacturer when allocating vaccines through the COVAX facility.
More News:
